Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP08 - Multimodality Management of Advanced Lung Cancer

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Multimodality of Advanced Lung Cancer
    • +

      FP08.04 - Tumour Spread Through Air Space (STAS) In Lung Metastases

      00:00 - 00:00  |  Presenter: Alberto Sandri

      • Abstract

      Loading...

  • +

    P14 - Immunotherapy (Phase II/III Trials) - Clinical Trial in Progress

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      P14.03 - Vibostolimab Plus Pembrolizumab With/Without Docetaxel vs Docetaxel in NSCLC After Platinum Chemotherapy and Immunotherapy

      00:00 - 00:00  |  Presenter: Solange Peters

      • Abstract

      Loading...

  • +

    P42 - Multimodality of Advanced Lung Cancer - Prognostic Factors

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Multimodality of Advanced Lung Cancer
    • +

      P42.01 - Tumor Size is an Independent Prognostic Factor after Pulmonary Metastasectomy

      00:00 - 00:00  |  Presenter: Simona Sobrero

      • Abstract

      Loading...

  • +

    P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      P45.12 - Renal Function Change During Alectinib in ALK Rearranged Non-Small Cell Lung Cancer: A Retrospective Multicentre Analysis

      00:00 - 00:00  |  Presenter: Chiara Paratore

      • Abstract

      Loading...

  • +

    P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • +

      P59.20 - Natural History of KRAS Mutant Non-Small-Cell Lung Cancer in the Immunotherapy Era: A Single-Centre Retrospective Study

      00:00 - 00:00  |  Presenter: Paolo Bironzo

      • Abstract

      Loading...

  • +

    IS08 - Industry Symposium Sponsored by Eli Lilly And Company: Personalizing and Optimizing Treatment for Metastatic NSCLC Patients with EGFR Mutations - Is There More We Can Do?

    • 05:45 - 06:45
    • 9/10/2021
    • Location: Industry Symposium Auditorium via Industry Hub
    • Not for CME Credit
    • Type: Industry Supported Symposium
    • Track: N.A.
    • +

      IS08.02 - Is a One Size Fits All Approach Still Appropriate for NSCLC with an EGFR Mutation, Are All Mutations Equal?

      05:50 - 06:05  |  Presenter: Silvia Novello

      • Abstract

      No abstract available for this presentation

  • +

    MA12 - The Impact of COVID-19 on How We Treat Thoracic Cancer Now and in the Future

    • 20:00 - 21:00
    • 9/12/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      MA12.07 - Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center

      20:40 - 20:45  |  Presenter: Maristella Bungaro

      • Abstract

      Loading...

  • +

    OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic

    • 20:00 - 21:00
    • 9/12/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Nursing and Allied Health Professionals
    • +

      OA17.04 - The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers

      20:30 - 20:40  |  Presenter: Anne-Marie Baird

      • Abstract

      Loading...

  • +

    PL05 - Plenary 5: Closing Plenary: Immunotherapy and Beyond: Future Directions (Japanese, Mandarin, Spanish Translation Available)

    • 21:15 - 22:15
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL05.01 - CAR T-cell Therapy for Thoracic Cancers

      21:15 - 21:27  |  Presenter: Prasad Adusumilli

      • Abstract

      Loading...

    • +

      PL05.02 - Determinants of Immunotherapy Resistance in Lung Cancer

      21:27 - 21:39  |  Presenter: Kurt Schalper

      • Abstract

      No abstract available for this presentation

    • +

      PL05.03 - Radiation/IO Synergy/Evolving Technology

      21:39 - 21:51  |  Presenter: Ken Harada

      • Abstract

      No abstract available for this presentation

    • +

      PL05.04 - IO in the Surgical Resectable Patient

      21:51 - 22:03  |  Presenter: Jamie Chaft

      • Abstract

      No abstract available for this presentation

    • +

      PL05.05 - Live Discussion with Speakers

      22:03 - 22:13

      • Abstract

      No abstract available for this presentation

    • +

      PL05.06 - Closing Remarks

      22:13 - 22:15

      • Abstract

      No abstract available for this presentation